Press Releases

Year

28 Feb '24

Veradigm Receives Expected Delisting Notice from Nasdaq

Continues to Work Diligently Towards Regaining Compliance CHICAGO --(BUSINESS WIRE)--Feb. 28, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology products and solutions, announced today that, as expected, it received a notice from The Nasdaq Stock Market LLC

PDF Version

27 Feb '24

Veradigm Provides Update on its Financial Restatement Process

Expects Not to File Required Financial Statements by Nasdaq’s February 27, 2024 Deadline Working Diligently to File Required Financial Statements and Restore Listing Adopts Limited Duration Stockholder Rights Plan CHICAGO --(BUSINESS WIRE)--Feb. 27, 2024-- Veradigm Inc.

PDF Version

27 Feb '24

Veradigm to Acquire ScienceIO

Veradigm to Leverage ScienceIO’s Leading Healthcare Artificial Intelligence (AI) Platform on the Company’s Large-Scale, High-Quality Data Set to Build Advanced, Private Language Models for Healthcare Expected to Provide Highly Differentiated and More Advanced Products to Veradigm Customers

PDF Version

22 Feb '24

Veradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 Conference

Recently debuted Veradigm Payer Insights is delivering care cap alerts to thousands of providers and growing fast as demand for payer-provider interoperability continues to increase CHICAGO --(BUSINESS WIRE)--Feb. 22, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and

PDF Version

20 Feb '24

Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.

Using de-identified data for 53 million unique cardiovascular patients, the report examines prevalence across all 50 states and a variety of demographics CHICAGO --(BUSINESS WIRE)--Feb. 20, 2024-- Which region of the U.S. has the highest rates of hypertension, coronary artery disease and heart

PDF Version

13 Feb '24

Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health

CHICAGO --(BUSINESS WIRE)--Feb. 13, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of Cardiology (ACC)-sponsored initiative aimed at improving cardiovascular health through

PDF Version

10 Jan '24

New Veradigm Leadership Provides Outlook on Business and Strategy, and Refreshed Financial Estimates for Fiscal 2023

CHICAGO --(BUSINESS WIRE)--Jan. 10, 2024-- The new leadership team at Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, has provided refreshed estimated, unaudited ranges of financial information for fiscal 2023. Dr.

PDF Version

04 Jan '24

Veradigm Leadership Team to Present at J.P. Morgan Healthcare Conference

CHICAGO --(BUSINESS WIRE)--Jan. 4, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Dr. Shih-Yin Ho , Veradigm interim Chief Executive Officer and board member, and Lee Westerfield , interim Chief Financial Officer, will

PDF Version

02 Jan '24

Veradigm Strengthens Award-Winning Revenue Cycle Services Portfolio with Acquisition of Full-Service RCM Company

CHICAGO --(BUSINESS WIRE)--Jan. 2, 2024-- Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the acquisition of Koha Health , a full-service revenue cycle management (RCM) company. With this acquisition, Veradigm further adds to its depth of

PDF Version

13 Dec '23

Veradigm Inc. Announces that Nasdaq Hearings Panel has Granted its Continued Listing, Pending Return to Compliance with Nasdaq Filing Requirements

CHICAGO --(BUSINESS WIRE)--Dec. 13, 2023-- Veradigm Inc. (NASDAQ: MDRX (the “Company”)) announced today that it received a decision from the Nasdaq Hearings Panel (the “Panel”) granting its request for continued listing on the Nasdaq Capital Market, subject to the Company demonstrating compliance

PDF Version

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Press Releases

Press Releases

Contact Investor Relations

Request E-mail Alerts